Abstract
Central retinal artery occlusion (CRAO) after a prolonged period of lying prone is a rare condition with only a handful of cases reported, generally as a postoperative complication of spinal surgery. Only a few cases can be found describing acute visual loss following intravenous drug abuse and stupor leading to continuous pressure on the orbit while asleep. No cases can be found describing acute visual loss following the ingestion of oral sedating/antipsychotic medications. Urgent identification and workup with subsequent interventions are needed to offer the highest probability of full/partial visual restoration. Our patient presented with complete vision loss after ingesting oral antipsychotic medications leading to a prolonged sedated state in which compressive ischemia led to central retinal artery occlusion. The complex timeline regarding the patient's presentation and the implications relating to offered interventions are highlighted in this case report.
Keywords: neuro-ophthalmology, hyperbaric oxygen therapy, intravenous drug use (ivdu), stroke, retinal injury, prescription drugs, blind, mri images, acute vision loss, central retinal artery occlusion
Introduction
"Saturday night retinopathy," a term coined by Jayam et al., describes a unique case of unilateral ischemic retinopathy identified in 1974. In this case, ischemic retinopathy was seen in the setting of stupor that led to continuous pressure on the orbit [1]. It was presumed that the underlying pathophysiology was similar to the complications of central retinal artery occlusion (CRAO) from direct pressure on the eye during prone surgical positioning [2]. Central retinal artery occlusion often presents with acute and profound loss of vision in one eye that is usually painless. It can occasionally present with transient monocular blindness, with either a stuttering or a fluctuating course [3]. CRAO almost never occurs in both eyes simultaneously [4]. Carotid artery atherosclerosis is the most common etiology for retinal artery occlusion overall but is relatively uncommon in patients under 40 years of age [5,6]. In patients under 40, the most likely etiology is cardiogenic embolism. Other vascular causes of CRAO include carotid artery dissection, fibromuscular dysplasia, radiation injury of the carotid or retinal arteries, Moyamoya disease, and Fabry disease. Nonvascular etiologies include hematological and inflammatory diseases such as leukemia/lymphoma, sickle cell disease, giant cell arteritis, and systemic lupus erythematosus. We present a young female with complete vision loss after ingesting oral antipsychotic medications. This led the female to experience a prolonged sedated state in which compressive ischemia further led to central retinal artery occlusion with possible involvement of the ophthalmic artery.
Case presentation
The patient is a 27-year-old female who presented to the emergency department (ED) with right monocular vision loss. Three days before her presentation, she reported falling asleep on her friend's couch, with her right eye resting on a hard metal portion of the couch frame. She reported that she had taken two tablets of quetiapine of an unknown dosage, which led to a prolonged state of sedation. She stated that she had never taken this medication before and used it in this isolated circumstance due to difficulty falling asleep. According to family members, the patient spent greater than 8-12 hours in this position. When she awoke several hours later, she found the orbit of her right eye swollen, to the extent that she was unable to open her eyelids. She immediately experienced vision loss in the right eye but attributed this to the significant swelling she was experiencing and the inability to open her right eye. She also reported a tingling sensation and numbness on her right face in an ophthalmic (V1) and maxillary branch (V2) distribution. She denied any significant pain other than soreness associated with the swelling. She denied any headaches, fevers, chills, palpitations, or any contralateral vision loss. After awakening, she delayed seeking medical attention. Three days after the inciting events, the swelling subsided enough for the patient to open her eyelid and realize that she was still experiencing vision loss. She then presented herself to a small community medical center. She underwent routine workup at the medical center, which then recommended urgent referral to ophthalmology services at our university center. Her past medical history was unremarkable, and the patient denied any history of drug abuse.
On arrival, vital signs showed a temperature of 97.2°F, a heart rate of 70 beats per minute (bpm), a respiratory rate of 18 respirations per minute (rpm), a systolic blood pressure of 106 mmHg and a diastolic blood pressure of 65 mmHg, and lastly an oxygen saturation (SpO2) of 98% while on room air. Physical examination showed a well-nourished young female in no acute distress. She had monocular right-sided total vision loss accompanied with marked limitation of abduction, supraduction, and infraduction and a modest abduction deficit of the right eye. She did have a loss of sensation in the forehead, face, maxillary area, and upper lip. She also displayed residual swelling with mild edema and erythema of the right lower lid. There was no sign of chemosis of the conjunctiva. Fundoscopic examination showed no significant edema but did show a cherry red macula with sharp optic disc margins and a pale retina. External ocular examination showed right ptosis and proptosis approximately 2-3 mm on the right side. The right pupil was dilated and unreactive to light and accommodation. Laboratory findings showed an unremarkable complete metabolic panel, as well as complete blood count (CBC). However, the patient's inflammatory markers were slightly elevated, and urine drug screen was positive for opioids and cannabinoids (Table 1).
Table 1. Laboratory results.
CRP, C-reactive protein; BUN, blood urea nitrogen
| Laboratory parameters | Value | Reference range |
| Sodium | 137 mEq/L | 136-145 mEq/L |
| Potassium | 4.5 mEq/L | 3.5-5.0 mEq/L |
| Chloride | 101 mEq/L | 95-105 mEq/L |
| Bicarbonate | 27 mEq/L | 22-28 mEq/L |
| BUN | 13 mg/dL | 7-18 mg/dL |
| Creatinine | 0.69 mg/dL | 0.6-1.2 mg/dL |
| Glucose | 97 mg/dL | 70-110 mg/dL |
| Calcium | 9.1 mg/dL | 8.4-10.2 mg/dL |
| Phosphorus | 3.1 mg/dL | 3.0-4.5 mg/dL |
| Magnesium | 2.1 mEq/L | 1.5-2.0 mEq/L |
| Hemoglobin | 13.4 g/dL | Female: 12.0-16.0 g/dL |
| Hematocrit | 41.60% | Female: 36%-46% |
| Leukocyte count | 9,400 per mm3 | 4,500-11,000 per mm3 |
| Platelet count | 315,000 per mm3 | 150,000-400,000 per mm3 |
| Neutrophil count | 4,900 per mm3 | 2,500-8,000 per mm3 |
| Lymphocyte count | 3,100 per mm3 | 1,000-4,000 per mm3 |
| Monocyte count | 500 per mm3 | 100-700 per mm3 |
| Eosinophil count | 800 per mm3 | 50-500 per mm3 |
| Basophil count | 0 per mm3 | 0-500 per mm3 |
| Erythrocyte sedimentation rate | 36 mm/hour | Female: 0-20 mm/hour |
| CRP | 0.6 mg/dL | 0.8-1.0 mg/dL |
| Opioids | Positive | |
| Cannabinoids | Positive |
Given the patient's presentation, she underwent further evaluation with computed tomography (CT) imaging, which showed no acute intracranial findings or evidence of orbital trauma (Figure 1). The magnetic resonance angiography (MRA) of the head and neck alongside the MRI of the brain was also unremarkable (Figures 2-3). The MRI of the orbits showed an unusual spectrum of signal abnormalities predominantly involving the preseptal right orbit but with the involvement of several intraorbital structures as described, including the posterior contour of the right globe, extraocular musculature, and optic nerve sheath (Figure 4).
Figure 1. CT imaging of the head.
CT of the head showed no evidence of hemorrhage, no mass effect, normal attenuation characteristics of the brain parenchyma, and ventricles normal for age. (A) Transverse CT imaging showing the bilateral orbits. (B) Sagittal CT imaging showing the right orbit. (C) Coronal CT imaging showing the bilateral orbits. (D) Transverse CT imaging showing the normal ventricles
CT: computed tomography
Figure 2. MRA imaging of the neck.
(A) Coronal MRA imaging showing the bilateral carotid arteries and all the major branching arteries of the neck. (B) Sagittal MRA imaging showing the carotid arteries and the vertebral arteries. Both common carotid and internal carotid arteries are widely patent. No significant atherosclerosis or stenosis at the carotid bifurcations upon NASCET criteria. The left vertebral artery is dominant. Both vertebral arteries are patent without focal stenosis. There is no significant stenosis in the cervical carotid and vertebral arteries as seen in the figure
MRA, magnetic resonance angiography; NASCET, North American Symptomatic Carotid Endarterectomy Trial
Figure 3. MRA imaging of the head.
(A) Transverse MRA imaging showing the circle of Willis. (B) Anterior-posterior MRA imaging showing the sagittal view of the circle of Willis. (C) Coronal MRA imaging showing the anterior view of the circle of Willis. (D) Detailed MRA imaging of the circle of Willis in the sagittal view, highlighting all the tributary arteries leading to the ophthalmic artery. The distal internal carotid, anterior, and middle cerebral arteries are widely patent. The distal vertebral arteries, basilar artery, and posterior cerebral arteries are widely patent. There is no evidence of aneurysm or focal stenosis. The image displays an unremarkable MRA of the head
MRA: magnetic resonance angiography
Figure 4. MRI imaging of the head.
The image shows that the right globe is intact, but there is mild right exotropia present. Subtle edema is present along the superior and lateral contour of the preseptal right orbit, which is best appreciated in the axial STIR images (A). There is a suspected mild extension of edema into the extraconal postseptal fat as in the coronal STIR image (C). Additional STIR signal abnormality with associated mild postcontrast enhancement is present along the posterior contour of the globe lateral to the optic nerve (A). There is mild asymmetric dilation of the right optic nerve sheath with flattening of the optic disc. There is suspected subtle hyperenhancement of the right optic nerve sheath as in the coronal image (B) immediately posterior to the globe. Abnormal T2 hyperintensity and hyperenhancement are present in the right superior and medial rectus muscles best seen in the coronal STIR image (C) and coronal postcontrast image (B). There is no drainable abscess identified, and no pathologic signal or pathologic enhancement is detected in the optic nerve proper. The cavernous sinuses enhance symmetrically
STIR: short TI inversion recovery
The patient was promptly started on vancomycin and ampicillin/sulbactam for fear of atypical orbital cellulitis presentation. The patient was also treated with hyperbaric oxygen therapy; however, this was more than 24 hours after the initial presentation in the ED. The patient was transported to the ophthalmology clinic for further evaluation and was found to have a cherry red spot on the macula, suggesting this could be CRAO. It was determined that her presentation was unlikely orbital cellulitis and likely CRAO with compression ischemia of the ophthalmic artery that may have caused ischemia in the third, fourth, fifth, V1, V2, and sixth cranial nerves. The vancomycin and ampicillin/sulbactam were subsequently discontinued, and the patient was discharged on hospital day 4 with oral Augmentin to finish a seven-day course and cover any possibility of orbital cellulitis.
Patient was evaluated by neuro-ophthalmology one week after discharge and was found to have persistent vision loss in the right eye along side minimal improvement of the extraocular muscle movement. The evaluation by neuro-ophthalmology determined that the patient likely had central retinal artery occlusion secondary to the compressive ischemia sustained during her prolonged sedated state. It was also determined that the patient had either compressive involvement of the ophthalmic artery leading to ophthalmoplegia or an orbital apex-like syndrome alongside the central retinal artery occlusion. The presence of ophthalmoplegia but the absence of any etiology leading to continued increased intraorbital pressure made orbital apex syndrome less likely. During the patient's follow-up visit, it was noted that she had retinal pigment epithelial atrophy but no evidence of a macular hole or edema (Figure 5). It was noted that the right eye had generalized narrowing of the retinal vessels consistent with the diagnosis of CRAO. The patient was subsequently lost to follow-up after her final visit with the retinal specialist.
Figure 5. Macular thickness measured in spectral domain optical coherence tomography (SD-OCT).
RPE, retinal pigment epithelium; ILM, internal limiting membrane
The ophthalmic artery arises as the first branch from the internal carotid artery. The ophthalmic artery then divides in branches that can be categorized as ocular group and orbital group. The orbital group includes the lacrimal artery, supraorbital artery, posterior ethmoidal artery, anterior ethmoidal artery, medial palpebral artery, frontal artery, and dorsal nasal artery. The ocular group includes the long posterior ciliary arteries, short posterior ciliary arteries, anterior ciliary artery, central retinal artery, superior muscular artery, and inferior muscular artery (Figure 6).
Figure 6. The ophthalmic artery and its branches.
Source: Häggström M: Medical gallery of Mikael Häggström 2014. Wiki J Med. 2014, 1:1-53. 10.15347/wjm/2014.008
Discussion
Central retinal artery occlusion (CRAO) after a prolonged period of lying prone is a rare condition with only a handful of cases reported in the past. Of the cases reported, it is found to be a rare operative complication in which a patient is lying prone for the duration of an operation, inadvertently lying with pressure on the external orbit. As a postoperative complication, vision loss has an estimated incidence of 0.01%-1% depending on the type of surgery [7,8]. The incidence of CRAO due to compression ischemia is not exactly known and is most likely to be a fraction of that. This case report highlights this rare etiology of CRAO as swift identification, and subsequent intervention is necessary to increase the likelihood of vision recovery.
Our patient had a mixed picture that had presenting symptoms indicative not only of CRAO but also of ophthalmic artery occlusion. The final diagnosis favored CRAO due to the limited involvement of the other branches that feed from the ophthalmic artery and the isolated nature of her ophthalmoplegia; it was thought that this may resemble an orbital apex-like syndrome, but in the absence of any residual compressive etiology, this was determined to be less likely. What is thought to have happened is that prolonged compression led to intense intraorbital swelling and compressive ischemia to the CRAO. The subsequent swelling and compression affected the CRA and the ophthalmic artery, but then, as the swelling subsided, the residual function of the retina was lost, and the remaining function of the V1/V2 was limited alongside the innervation of the extraocular muscles. This patient's final diagnosis from ophthalmology was CRAO with ophthalmic artery involvement.
CRAO is considered an ocular emergency. Animal studies suggest that the restoration of blood flow within 90-100 minutes leads to retinal injury, while occlusions persisting for longer than 240 minutes produce massive irreversible damage to the retina [9-12]. A review of treatment options for CRAO indicated that in order to be effective, treatment should be given within six hours of ischemia onset, regardless of the method utilized [12]. Revascularization should not be delayed when indicated, but in patients with CRAO secondary to compressive ischemia, the intervention of choice would be hyperbaric oxygen therapy. Hyperbaric oxygen therapy is used to maintain the oxygenation of the retina pending reperfusion. In a small series of patients, reperfusion has shown mixed results in attempts of preserving vision [13-15].
Some late ocular complications include a neovascular response in which enough portions of the retina survive under hypoxic conditions, leading to vascular formation. Neovascularization becomes apparent after two to three months [9,16-17]. Subsequent complications include vitreous hemorrhage and neovascular glaucoma. Long-term prognosis is dependent on time to treatment and presenting baseline visual loss.
Conclusions
Central retinal artery occlusion due to compression ischemia is an extremely rare complication of surgeries that involve prone positioning of the patient. Despite being an operative complication, it does not rule out the possibility of this occurring in a nonsurgical setting, in which a prolonged sedated state results in compressive ischemia and subsequent CRAO. Early identification and treatment are cornerstones of positive outcomes. Patients should be counseled on the judicious use of sedating medications and be made aware of this inadvertent and indirect complication of sedating medications in the outpatient setting.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained or waived by all participants in this study
References
- 1.Saturday night retinopathy. Jayam AV, Hass WK, Carr RE, Kumar AJ. J Neurol Sci. 1974;22:413–418. doi: 10.1016/0022-510x(74)90077-x. [DOI] [PubMed] [Google Scholar]
- 2.Saturday night retinopathy with ophthalmoplegia: a case series. Malihi M, Turbin RE, Frohman LP. Neuroophthalmology. 2015;39:77–82. doi: 10.3109/01658107.2014.997889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Relapsing and remitting central retinal artery occlusion. Werner MS, Latchaw R, Baker L, Wirtschafter JD. Am J Ophthalmol. 1994;15:393–395. doi: 10.1016/s0002-9394(14)72967-8. [DOI] [PubMed] [Google Scholar]
- 4.Central retinal artery occlusion. Appen RE, Wray SH, Cogan DG. Am J Ophthalmol. 1975;79:374–381. doi: 10.1016/0002-9394(75)90609-1. [DOI] [PubMed] [Google Scholar]
- 5.Retinal arterial occlusions in young adults. Greven CM, Slusher MM, Weaver RG. Am J Ophthalmol. 1995;120:776–783. doi: 10.1016/s0002-9394(14)72731-x. [DOI] [PubMed] [Google Scholar]
- 6.Retinal arterial obstruction in children and young adults. Brown GC, Magargal LE, Shields JA, Goldberg RE, Walsh PN. Ophthalmology. 1981;88:18–25. doi: 10.1016/s0161-6420(81)35080-5. [DOI] [PubMed] [Google Scholar]
- 7.Eye injuries after nonocular surgery. A study of 60,965 anesthetics from 1988 to 1992. Roth S, Thisted RA, Erickson JP, Black S, Schreider BD. Anesthesiology. 1996;85:1020–1027. doi: 10.1097/00000542-199611000-00009. [DOI] [PubMed] [Google Scholar]
- 8.The frequency of perioperative vision loss. Warner ME, Warner MA, Garrity JA, MacKenzie RA, Warner DO. Anesth Analg. 2001;93:1417–1421. doi: 10.1097/00000539-200112000-00013. [DOI] [PubMed] [Google Scholar]
- 9.Central retinal artery occlusion and retinal tolerance time. Hayreh SS, Kolder HE, Weingeist TA. Ophthalmology. 1980;87:75–78. doi: 10.1016/s0161-6420(80)35283-4. [DOI] [PubMed] [Google Scholar]
- 10.Central retinal artery occlusion. Retinal survival time. Hayreh SS, Zimmerman MB, Kimura A, Sanon A. Exp Eye Res. 2004;78:723–736. doi: 10.1016/s0014-4835(03)00214-8. [DOI] [PubMed] [Google Scholar]
- 11.Experimental occlusion of the central artery of the retina. IV: retinal tolerance time to acute ischaemia. Hayreh SS, Weingeist TA. Br J Ophthalmol. 1980;64:818–825. doi: 10.1136/bjo.64.11.818. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.A review of central retinal artery occlusion: clinical presentation and management. Varma DD, Cugati S, Lee AW, Chen CS. Eye (Lond) 2013;27:688–697. doi: 10.1038/eye.2013.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Early hyperbaric oxygen therapy for retinal artery occlusion. Beiran I, Goldenberg I, Adir Y, Tamir A, Shupak A, Miller B. Eur J Ophthalmol. 2001;11:345–350. doi: 10.1177/112067210101100405. [DOI] [PubMed] [Google Scholar]
- 14.Update on treatment of retinal arterial occlusions. Rumelt S, Brown GC. Curr Opin Ophthalmol. 2003;14:139–141. doi: 10.1097/00055735-200306000-00005. [DOI] [PubMed] [Google Scholar]
- 15.Early hyperbaric oxygen treatment for nonarteritic central retinal artery obstruction. Menzel-Severing J, Siekmann U, Weinberger A, Roessler G, Walter P, Mazinani B. Am J Ophthalmol. 2012;153:454–459. doi: 10.1016/j.ajo.2011.08.009. [DOI] [PubMed] [Google Scholar]
- 16.Iris neovascularization associated with obstruction of the central retinal artery. Duker JS, Brown GC. Ophthalmology. 1988;95:1244–1250. doi: 10.1016/s0161-6420(88)33042-3. [DOI] [PubMed] [Google Scholar]
- 17.A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization. Duker JS, Sivalingam A, Brown GC, Reber R. Arch Ophthalmol. 1991;109:339–342. doi: 10.1001/archopht.1991.01080030041034. [DOI] [PubMed] [Google Scholar]






